Peptide receptor radionuclide therapy (PRRT) is a molecular therapy used to treat cancers, particularly neuroendocrine tumors, by delivering targeted radiation directly to cancer cells via radiolabeled peptides that bind to specific receptors on the tumor. This targeted approach minimizes damage to surrounding healthy tissues, enhancing treatment efficacy and reducing side effects compared to conventional radiotherapy.